ライフサイエンスコーパス: diagnostic

1 a can help maximize utility of this emerging diagnostic.

2 mpedance provides a specific but insensitive diagnostic.

3 in a closed tube, undiluted sample molecular diagnostic.

4 retable results for phenotype-driven genomic diagnostics.

5 examination training and home-based patient diagnostics.

6 equires rapid, cheap, scalable, and accurate diagnostics.

7 role of non-obstructive CAD patients in CAD diagnostics.

8 have shown potential in noninvasive prenatal diagnostics.

9 atform with great potential in point-of-care diagnostics.

10 of visual and electronic readouts for use in diagnostics.

11 , sports performance monitoring, and medical diagnostics.

12 ional connections" for maps and neurological diagnostics.

13 ed a new era of nucleic acid-based molecular diagnostics.

14 Nuclear staining percentage has a fair diagnostic ability for CRC with an AUC of 0.63 (95%CI =

15 across multiple institutions, exceeding the diagnostic ability of radiologists with specialized head

16 Both AECs and NECs might provide better diagnostic accuracy and efficacy levels than PBMCs.

17 The diagnostic accuracy as measured by the area under the re

18 The diagnostic accuracy can be improved by assessing the bre

19 ion analytic models to determine the minimum diagnostic accuracy criteria for NITs to diagnose cirrho

20 rdial perfusion CMR and LGE imaging had high diagnostic accuracy for CAD in 2 phase 3 clinical trials

21 ary capillary density parameters showed good diagnostic accuracy for detecting glaucoma in ED patient

22 dalities are associated with improvements in diagnostic accuracy for the staging and response assessm

23 Our data suggests that the diagnostic accuracy of CT-FFR in this cohort potentially

24 The diagnostic accuracy of KLK8 in CSF and blood was determi

25 This study aimed to investigate the diagnostic accuracy of orbital imaging to diagnose orbit

26 tic curve analysis was used to determine the diagnostic accuracy of quantitative metrics, using visua

27 is study determined, for the first time, the diagnostic accuracy of quantitative micro-elastography (

28 OCT did not improve the diagnostic accuracy of the TECS protocol when compared w

29 The diagnostic accuracy of the test was compared with that o

30 We aimed to determine the diagnostic accuracy of three-dimensional magnetic resona

31 a detection, radiologists achieved a maximum diagnostic accuracy of up to 0.87 (95% CI, 0.78-0.93) wh

32 Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) was applied for

33 ged as another IE imaging modality, although diagnostic accuracy varies across observational studies

34 elect the optimal combination of biomarkers, diagnostic accuracy was determined using area under the

35 Diagnostic accuracy was evaluated by the agreement with

36 for detecting glaucoma in ED patients, their diagnostic accuracy was only modest in AD patients.

37 s are suitable in terms of image quality and diagnostic accuracy.

38 ured and defined with a head-mounted display diagnostic algorithm.

39 with diagnosis according to the 10/66 Study diagnostic algorithm.

40 and diabetes is uncertain despite important diagnostic and management implications.

41 idence for thromboembolic disease, potential diagnostic and preventive actions, and recommendations f

42 Logistic regression and random forests using diagnostic and procedure codes as well as sociodemograph

43 RNA and a further improvement in miRNA-based diagnostic and prognostic applications.

44 Sensitive and specific diagnostic and prognostic biomarkers for prostate cancer

45 in cancer can also serve as a biomarker for diagnostic and prognostic purposes.

46 s cell-specific DNA methylation patterns for diagnostic and prognostic purposes.

47 the use of plasma p-tau181 as a non-invasive diagnostic and prognostic tool for AD, regardless of cli

48 s with first onset of a depressive disorder (Diagnostic and Statistical Manual of Mental Disorders IV

49 ental biology as well as developing improved diagnostic and theranostic systems.

50 orders, focusing on their clinical features, diagnostic and therapeutic approaches are presented.

51 ntegrates with interventional trials in both diagnostic and therapeutic arenas.

52 n angiogenesis that has potential to provide diagnostic and therapeutic insights.

53 Conclusion: Both diagnostic and therapeutic nuclear medicine procedures d

54 leukemogenesis will be crucial for improving diagnostic and therapeutic options for patients.

55 The diagnostic and therapeutic potential of (64)Cu and (67)C

56 sequencing efforts are identifying potential diagnostic and therapeutic targets more rapidly than exi

57 provide a new and expanding armamentarium of diagnostic and therapeutic tools to treat patients with

58 bset of binding sites with immense potential diagnostic and therapeutic utility.

59 hold group, but that group had more invasive diagnostic and treatment interventions.

60 These ageotypes open new avenues to creating diagnostic and treatment strategies that may slow the ag

61 ifferent from published approaches, we offer diagnostic and validation tools for all relevant steps.

62 ith a broad range of applications in medical diagnostics and analytical chemistry.

63 biomarkers plays important roles in clinical diagnostics and biomedical research.

64 sts between availability of state-of-the-art diagnostics and current needs.

65 A universal SP test would simplify frontline diagnostics and facilitate large-scale serological surve

66 ing provides new opportunities for molecular diagnostics and image-guided biomedical applications.

67 s in allergen and epitope discovery, allergy diagnostics and immunotherapy.

68 rious diseases with well-known biomarkers in diagnostics and monitoring, especially with potential fu

69 ology as well as to the development of early diagnostics and personalized therapies.

70 monitoring become crucial to allow specific diagnostics and the effective monitoring of the associat

71 hysiological signals for self-powered health diagnostics and therapeutics.

72 From these data, we propose a surveillance, diagnostic, and management strategy that balances potent

73 ocess involved in cellular behavior, medical diagnostics, and material fabrication.

74 ossible applications in complement research, diagnostics, and therapeutics.

75 w that PRSs were associated with SCZ and MDD diagnostics, and with cognition in SCZ and pathology in

76 s enormous potential in both therapeutic and diagnostic applications.

77 This may enable future non-invasive diagnostic applications.

78 single cells therefore offers many potential diagnostic applications.

79 a sensitive biosensor for DNA detection and diagnostic applications.

80 omarker detection, and protein profiling for diagnostic applications.

81 nce, providing a low-cost, fast and accurate diagnostic approach.

82 r evaluation will most likely offer the best diagnostic approach.

83 Current diagnostic approaches are based on discordant measures,

84 CRISPR-based diagnostic approaches are proving to be useful as field-

85 Noninvasive diagnostic approaches provide an opportunity to avoid su

86 Current state of the art diagnostics are highly sensitive and specific, but slow,

87 ay for M. leprae, were validated as clinical diagnostic assays according to Clinical Laboratory Impro

88 analysis may serve as a parameter for future diagnostic assays for women with breast implants to dist

89 el of P. malariae to study parasite biology, diagnostic assays, and treatment.

90 ing at single-cell resolution, revealing new diagnostic biomarkers and potential therapeutic targets

91 In contrast, there is still a lack of diagnostic biomarkers of functional dystonia and tics, w

92 s new approach could potentially lead to new diagnostic biomarkers or inform clinical interventions t

93 uent application to an independent series of diagnostic biopsies replicated the subgroups, with immun

94 Controllable, precise, and safe delivery of diagnostic biosensing devices and therapeutic agents to

95 SVD biomarkers on the diagnostic brain CT are associated with 1-year death and

96 tting edge biochemical techniques, including diagnostics, by making portable and electricity-free hea

97 of patients with suspected PVE increases the diagnostic capability of the modified Duke criteria.

98 rameters using routine statistics, while the diagnostic capacity of individual parameters and overall

99 h Domain Criteria, an attempt to move beyond diagnostic categories and ground psychiatry within neuro

100 ny experts believe that existing psychiatric diagnostic categories included in DSM and ICD are actual

101 of ENE on pretreatment imaging represents a diagnostic challenge that limits its clinical utility.

102 stroke (IS) from stroke mimics (SMs) poses a diagnostic challenge.

103 malignant and malignant biology of ROS1, the diagnostic challenges that ROS1 fusions present and the

104 rated molecular classification is to improve diagnostic classification, risk stratification and assig

105 International Classification of Diseases diagnostic codes are used to estimate acute gastroenteri

106 The goal of this study was to explore diagnostic colonoscopy completion in adults with abnorma

107 as to determine patient-reported barriers to diagnostic colonoscopy following abnormal FIT in an acad

108 al of 114 F(2) families were screened with a diagnostic concentration of 3.0 mug/cm(2) of Vip3Aa39 pr

109 Diagnostic confirmation of CTEPH is provided by digital

110 ntary staging modality which also allows for diagnostic confirmation when combined with fine needle a

111 re features in common, more than current DSM diagnostic constructs, also provide better prognostic ac

112 tal sampling was achievable at no additional diagnostic cost to the FCU/VVS.

113 These elements include clinical diagnostic criteria and genetic testing; risk restratifi

114 Diagnostic criteria and procedure codes were used to ide

115 in myeloid-related genes, but still, current diagnostic criteria do not include molecular data.

116 professional who is knowledgeable about the diagnostic criteria for gender dysphoria and criteria fo

117 across the country, 269 (7.6%) satisfied the diagnostic criteria for GERD, while 107 (3.0%) had GERD

118 cipants had phenotypic features that met the diagnostic criteria for more than one syndrome.

119 sorder not by HR, each fulfilled appropriate diagnostic criteria.

120 ts' awareness of this condition and to avoid diagnostic delay and unnecessary use of antibiotics, hos

121 e a prior psychiatric diagnosis, and average diagnostic delay is up to 5-6 years from symptom onset.

122 Diagnostic efficacy is evaluated by a panel of hematolog

123 The overall diagnostic efficacy of combined GS and SoC approaches wa

124 CD5, MIP-1a, and CXCL9 which had a combined diagnostic efficacy similar to immunoglobulin G (IgG) in

125 of COVID-19 related markers for therapeutic, diagnostic, epidemiologic, and prognostic purposes.

126 ting has become an integral component of the diagnostic evaluation of patients with suspected primary

127 laced at different positions in the order of diagnostic evaluations, depending on clinical presentati

128 4 tumor samples demonstrated presence of the diagnostic EWSR1-WT1 translocation and these 12 samples

129 screening; 247 were reviewed weekly by a VIA diagnostic expert.

130 members with high scores across three broad diagnostic families of disorders (externalizing, interna

131 s developing antibody-based therapeutics and diagnostics for CoV-2.

132 safe and effective vaccines, therapies, and diagnostics for SARS- coronavirus 2 (CoV-2), the develop

133 deprotonated or formate-adducted GPLs yields diagnostic fragment ions spaced 24 Da apart.

134 There are three proposed PG diagnostic frameworks (Su, PARACELSUS, Delphi); however,

135 valuate and compare the concordance of these diagnostic frameworks within a single-institution cohort

136 ant for many applications including clinical diagnostics, functional proteomics, and drug discovery.

137 Common genetic variants in a diagnostic gene panel of 396 autosomal intellectual disa

138 udy, a randomized, controlled trial of rapid diagnostic genomic sequencing of infants in regional ICU

139 The following diagnostic groups were compared: typically developing yo

140 ohistochemistry (IHC) (n = 64), on four main diagnostic groups-SAGN, primary IgAN, acute tubular necr

141 d outcomes for rapid intervention with rapid diagnostics have been documented and include decreased m

142 rch teams and their application in PCR-based diagnostics, high-affinity DNA aptamer generation, site-

143 Combining conventional diagnostics (histology, serology, and clinical data) and

144 nistered-activity data and evaluation of the diagnostic image quality at baseline; comparison of base

145 cipants' radiation exposure while preserving diagnostic image quality.

146 tween December 2012 and February 2018 in the diagnostic imaging department at the Hospital Clinico Un

147 uss the current and novel approaches for the diagnostic imaging of cardiac amyloidosis.

148 in humans and its use as a research tool for diagnostic imaging of obesity/diabetes, bacterial infect

149 er recorded surface geometries, and standard diagnostic imaging procedures provided tumor sizes and s

150 ical value of Rapid Estimation of Myelin for Diagnostic Imaging, a new myelin imaging technique based

151 Among many accessible tools in diagnostic imaging, IVIM MRI aroused the interest of man

152 The diagnostic impact of (18)F-FLT PET/CT was highest after

153 ss the need for better screening and medical diagnostics in all areas of disease.

154 or early detection, prognosis, and companion diagnostics in breast cancer.

155 a new diagnostic test developed in the Rapid Diagnostics in Categorizing Acute Lung Infections (RADIC

156 IV-positive inpatients with sputum and urine diagnostics in Malawi and South Africa (Rapid urine-base

157 8)Ga-PSMA-guided bone biopsies for molecular diagnostics in mPC patients.

158 ent can maintain the fidelity of video-based diagnostics in the face of missing values and variable v

159 Our use of a non-diagnostic inclusion strategy may have overlooked certai

160 on) in retinal vessels may serve as a useful diagnostic indicator of disease progression and as a the

161 n the amides and the water, thereby yielding diagnostic information about solvent accessibility.

162 Our aim is focusing on the main diagnostic issues.

163 em has an array of highly sensitive in vitro diagnostic (IVD) real-time PCR assays for respiratory vi

164 sent a challenge to clinical geneticists and diagnostic laboratories.

165 Although there are no diagnostic laboratory or imaging tests which are specifi

166 As our diagnostic laboratory was not equipped for reagent produ

167 has considerable potential to reshape the TB diagnostics landscape, making diagnosis and treatment in

168 Tracking diagnostic lipid DB-position fragment ions in mouse panc

169 association of microglial markers at time of diagnostic lumbar puncture (LP) with different aspects o

170 In response, many diagnostic manufacturers have developed molecular assays

171 llular carcinoma (HCC) and is an independent diagnostic marker predicting the poor prognosis of HCC p

172 tercepted in the blood, could serve as early diagnostic markers.

173 eing studied as promising minimally invasive diagnostic markers.

174 iduals, which could be employed as potential diagnostic markers.

175 us classifications into a treatment-oriented diagnostic matrix.

176 linical awareness and access to simple rapid diagnostics may improve the diagnosis of blastomycosis i

177 nterpreter-assisted or native language), and diagnostic measure.

178 is urgent need to develop and deploy robust diagnostic methodologies not only to use in health labor

179 th a short turnaround time compared to other diagnostic methods.

180 e myriad of currently employed screening and diagnostic methods.

181 ancreas is increasingly used as an important diagnostic modality for characterisation of pancreatic l

182 The diagnostic monocular VF testing algorithm was comparable

183 onfirmed rectal cancer and underwent routine diagnostic MRI, an extended diffusion-weighted sequence,

184 onduct research on key unmet therapeutic and diagnostic needs in the field of TB elimination using mu

185 ed behavioral diagnostic tools is the Autism Diagnostic Observation Schedule (ADOS).

186 Furthermore, the diagnostic odds ratio of YEARS was higher than Wells' sc

187 ting characteristic curve (AUC) analysis and diagnostic odds ratios against both reference standards.

188 Carlsson- Dent questionnaire was considered diagnostic of gastroesophageal reflux symptoms (GERD).

189 eriments, awareness and confidence were more diagnostic of the prospective decision than task correct

190 ed to develop new criteria for comprehensive diagnostics of autoimmune diseases, based not only on tr

191 ally, RS can be used for Huanglongbing (HLB) diagnostics on both orange and grapefruit trees, as well

192 We propose three main diagnostic pathways with distinct biomarker sequences, i

193 Early T1 shortening showed high diagnostic performance (area under the receiver operatin

194 ), and PCT <0.25 mug/L (AUC = 0.81) improved diagnostic performance (AUC = 0.90) (P = .05).

195 Diagnostic performance and agreement with scores assigne

196 n analysis of both parameters enhanced their diagnostic performance and provided excellent predictabi

197 s diagnostic-quality scans and evaluated the diagnostic performance and safety in a phase III study o

198 The diagnostic performance for identifying none-to-low vs. i

199 Gadolinium-based contrast agents improved diagnostic performance in detection of recurrent soft-ti

200 hetic CT of the sacroiliac joints has better diagnostic performance in the detection of structural le

201 We evaluated the diagnostic performance of select clinical features again

202 Diagnostic performance was assessed as a function of lyt

203 Reader diagnostic performance was evaluated with receiver opera

204 neural network is feasible and achieves high diagnostic performance when both CT and PET images are u

205 Doppler measurements gave a similar level of diagnostic performance with less uncertainly.

206 risons, showing nearly a 20% increase in its diagnostic performance.

207 g the different DNA isolation techniques and diagnostic performance.

208 multiple sclerosis, and evaluated for their diagnostic performance.

209 , (2) physical exam, (3) family history, (4) diagnostic phenotypic testing, and (5) variant correlati

210 encouraging further research to explore the diagnostic potential and the functional role of these al

211 While their regulatory and diagnostic potential has gained a substantial amount of

212 risk of disease to be targeted for in depth diagnostic procedures and early interventions.

213 PET, particularly in comparison to standard diagnostic procedures such as MRI or (123)I-MIBG SPECT/C

214 ditures include paying for general medicine, diagnostic procedures, hospitalizations and surgeries, a

215 t lncRNAs have the potential to be promising diagnostic, prognostic biomarkers and therapeutic target

216 ificance in HSP-7 patients, both in terms of diagnostic/prognostic biomarkers and novel pharmacologic

217 The development of new diagnostic, prophylactic, therapeutic and curative strat

218 Use of the LIPS assay to identify putative "diagnostic" proteins would be a valuable asset in determ

219 est dose of (64)Cu-DOTATATE that facilitates diagnostic-quality scans and evaluated the diagnostic pe

220 The survey included the Rome IV Diagnostic Questionnaire, Rome III irritable bowel syndr

221 als separately using AI models, and obtain a diagnostic rate of close to 100 percent (100% for hospit

222 Different diagnostic ratios revealed sterols originating from huma

223 activity (RHI) scores the test improved its diagnostic reliability.

224 our findings emphasize the need for improved diagnostic/risk prediction strategies to guide antibioti

225 ions in vivo, which may serve prognostic and diagnostic roles.

226 ective therapy have led to rapid adoption of diagnostic scintigraphy, there is heterogeneity in adher

227 While blue light cystoscopy improves diagnostic sensitivity, it remains a costly and invasive

228 t transferable pathogens requiring practical diagnostic setups to control their transfer chain and st

229 we find no evidence for a distinct microbial diagnostic signature, probably due to heterogeneous host

230 notypes, and leading to improvements in both diagnostic strategies and functional characterization of

231 H across disease remain elusive, and current diagnostic strategies do not provide localization of pH

232 g has emerged as one of the most informative diagnostic techniques.

233 New diagnostic technology, new toric IOLs, updated lens form

234 for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA) was follow

235 apply the AWA methodology to evaluate a new diagnostic test developed in the Rapid Diagnostics in Ca

236 RT-RPA is a reliable diagnostic test for asymptomatic low-density infections.

237 n against the use of Xpert Ultra as a single diagnostic test for TBM; it cannot be used to "rule out"

238 anel (QIAstat-Dx RP) is a multiplex in vitro diagnostic test for the qualitative detection of 20 path

239 analysis should be implemented as a routine diagnostic test in meningioma and integrated into the WH

240 A rapid and early diagnostic test to identify the encephalopathic babies a

241 argeted sequencing panel as a cost-effective diagnostic test, especially in cancers such as acute leu

242 c of diagnostic yield or global utility of a diagnostic test.

243 eity has hindered development of a molecular diagnostic test.

244 ion (LAMP) was compared to traditional rapid diagnostic testing (RDT) for the improved detection of i

245 tories in their effort to achieve sufficient diagnostic testing capability for identifying infected i

246 ant need for improved stewardship related to diagnostic testing for and treatment of IFIs.

247 No recent data have investigated rates of diagnostic testing for pulmonary embolism (PE) in US eme

248 Our recommendation for SARS-CoV-2 diagnostic testing is to select an assay with high sensi

249 correct identification of each disease when diagnostic testing occurs either simultaneously or seque

250 Current diagnostic testing only partially predicts this clinical

251 favorably with a commercial product used for diagnostic testing.

252 Owing to limitations of current diagnostic tests (i.e., poor sensitivity and delayed res

253 h SP against intermittent screening by rapid diagnostic tests (ISTp).

254 r guidelines and algorithms, available rapid diagnostic tests (RDTs) for common acute undifferentiate

255 er incorporating dual HIV and syphilis rapid diagnostic tests as the first test in antenatal care to

256 Currently available diagnostic tests for Clostridioides difficile infection

257 nning and echocardiography being the initial diagnostic tests if CTEPH is a concern.

258 Incorporating dual rapid diagnostic tests in antenatal care can be cost-saving ac

259 uated for tuberculosis (TB), a lack of rapid diagnostic tests which can fully describe TB resistance

260 nduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies.

261 to food safety to the most frequent in vitro diagnostic tests, partially conducted in automated sampl

262 In particular, point-of-care diagnostics that are able to reduce and/or prevent unnee

263 However, culture-based diagnostics that are time-consuming remain the gold stan

264 e been broadly studied in different areas of diagnostics, they are not yet fully commercialized.

265 owever, there is variation in the ultrasound diagnostic thresholds used to determine disease severity

266 e studies across the spectrum of image-based diagnostics to improve human-computer collaboration in c

267 ge transcriptionally upon stress exposure as diagnostics to predict antibiotic sensitivity.

268 bolomic approaches hold a great promise as a diagnostic tool for inborn errors of metabolisms (IEMs)

269 It was an accurate diagnostic tool for IR prediction in males, but not nece

270 roscopic imaging may serve as a quantitative diagnostic tool for quantitatively tracking disease prog

271 application of whole-genome sequencing as a diagnostic tool is leading to the profiling of drug resi

272 rcumference (MUAC) is used as an independent diagnostic tool to detect wasting in children aged 6-59

273 e review current knowledge gaps and existing diagnostic tools and algorithms.

274 Rapid and accurate diagnostic tools are needed for appropriate management o

275 Capitalizing on this knowledge, novel diagnostic tools can be developed to guide clinical diag

276 Low-cost non-invasive diagnostic tools for staging the progression of non-alco

277 One of the most widely used behavioral diagnostic tools is the Autism Diagnostic Observation Sc

278 ous challenges in the development of in vivo diagnostic tools.

279 IMI and highlights the potential benefit of diagnostics tools to identify S. aureus CC during bovine

280 ng requested to confirm injury or to resolve diagnostic uncertainty.

281 e well-calibrated CP estimates for precision diagnostics using DNA methylation data.

282 The diagnostic utility of tau368 was first evaluated in a pi

283 in early LB and a demonstration of potential diagnostic utility.

284 D and their combination provided an improved diagnostic value for NTM-PD.

285 the emerging evidence of BDNF as a potential diagnostic value in CAD that might lead to clinical appl

286 the previously irradiated volume to improve diagnostic value in patients for whom histologic confirm

287 cross-reactivity and cross-protectivity, the diagnostic value of antibodies of different isotypes, an

288 To investigate the diagnostic value of the temporal radiographic changes, a

289 ltiple primary malignancies represents added diagnostic value.

290 We assessed the diagnostic values of serum biomarkers in the differentia

291 iveness of implementing a stepwise objective diagnostic verification algorithm among patients with co

292 More recently, a newer generation of diagnostics with immense potential has emerged, includin

293 both expert and non-expert clinicians in the diagnostic work-up of MCDs with the aim of improving pat

294 Here, we show an N. gonorrhoeae diagnostic workflow for analysis of metagenomic sequenci

295 g specific sequences should be a part of the diagnostic workup to detect a possible neurovascular con

296 The diagnostic yield across strategies and population subgro

297 pproach in the diagnosis of PID can increase diagnostic yield and further our understanding of the ke

298 The workflow is designed to maximize the diagnostic yield and increase the number of patients rec

299 cy (AWA), representing a pragmatic metric of diagnostic yield or global utility of a diagnostic test.

300 The secondary outcomes were the molecular diagnostic yield, the change in clinical management afte